1. Mechanisms of sensitivity or resistance of murine tumor to N-(phosphonacetyl)-l-aspartate (PALA);Jayaram;Cancer Treatment Rep,1979
2. Therapeutic utility of utilizing low doses of N-(phosphonacetyl)-l-aspartic acid in combination with 5-fluorouracil: a murine study with clinical relevance;Martin;Cancer Res,1983
3. Improving antitumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation;Spiegelman;Proc Natl Acad Sci USA,1980
4. Antitumor activity of the weekly intravenous push schedule of 5-fluoro-2'-deoxyuridine ±N-phosphonacetyl-l-aspartate in mice bearing advanced colon carcinoma 26;Van Laar;Cancer Res,1993
5. Phase II study of biochemical modulation of fluorouracil by low dose PALA in patients with colorectal cancer;O'Dwyer;J Clin Oncol,1990